Calif. company still focus of cyclosporiasis outbreak investigation, FDA says

Calif. company still focus of cyclosporiasis outbreak investigation, FDA says
FacebookXWhatsAppEmail

There are "no confirmed positive sample results" at this time, according to the FDA.